Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem

Ufer, M; Kelsh, D; Schoedel, KA; Dingemanse, J

Dingemanse, J (通讯作者)，Idorsia Pharmaceut Ltd, Dept Clin Pharmacol, Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland.

SLEEP, 2022; 45 (3):

Abstract

Study Objectives: Abuse potential properties have been reported for the dual orexin receptor antagonists (DORAs) suvorexant and lemborexant. Daridorex......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索